Scientific

MK5 Microarray Data


Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 2363 to 2412 of 3228 in total
Value Type: Measured
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1
\def\wcA{0.16666666666667\textwidth} \def\wcB{0.16666666666667\textwidth} \def\wcC{0.16666666666667\textwidth} \def\wcD{0.16666666666667\textwidth} \def\wcE{0.16666666666667\textwidth} \begin{longtable}{|c|c|c|c|c|} \hline \parbox{\wcA}{\vspace{3pt}\noindent Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent network\_comparison\vspace{3pt}}\\ \hline \hline \parbox{\wcA}{\vspace{3pt}\noindent 2363\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent glutamate--cysteine ligase regulatory subunit (ec 6.3.2.2) (gamma- glutamylcysteine synthetase) (gamma-ecs) (gcs light chain) (glutamate--cysteine ligase modifier subunit). [source:swissprot;acc:p48507]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 6822.6\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 6539.8\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.04324\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 2364\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent glutamate--cysteine ligase catalytic subunit (ec 6.3.2.2) (gamma- glutamylcysteine synthetase) (gamma-ecs) (gcs heavy chain). [source:swissprot;acc:p48506]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2365\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent bai1-associated protein 1; ww domain-containing protein 3; atrophin-1 interacting protein 3. [source:refseq;acc:nm\_004742]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5254.55\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 5480.56\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.04301\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2366\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent geranylgeranyl transferase type i beta subunit (ec 2.5.1.-) (type i protein geranyl-geranyltransferase beta subunit) (ggtase-i-beta). [source:swissprot;acc:p53609]\vspace{3pt}}&\multirow{5}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 5265.95\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 5492.28\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.04298\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 2367\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent fatty acid desaturase 3; linoleoyl-coa desaturase (delta-6-desaturase)-like 3; delta-6 fatty acid desaturase. [source:refseq;acc:nm\_021727]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 2368\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent mothers against decapentaplegic homolog 4 (smad 4) (mothers against dpp homolog 4) (deletion target in pancreatic carcinoma 4) (hsmad4). [source:swissprot;acc:q13485]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 2369\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent fatty acid desaturase 2; linoleoyl-coa desaturase (delta-6-desaturase)-like 2; delta-6 fatty acid desaturase. [source:refseq;acc:nm\_004265]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 2370\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent fatty acid desaturase 1; linoleoyl-coa desaturase (delta-6-desaturase)-like 1; delta-5 desaturase; delta-5 fatty acid desaturase. [source:refseq;acc:nm\_013402]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2371\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent dna-directed rna polymerase ii 13.3 kda polypeptide (ec 2.7.7.6) (rpb11). [source:swissprot;acc:p52435]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 4668.29\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 4868.52\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.04289\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2372\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 60s ribosomal protein l12, mitochondrial precursor (l12mt) (5c5-2). [source:swissprot;acc:p52815]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 3677.53\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 3526.65\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.04278\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 2373\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent nudix (nucleoside diphosphate linked moiety x)-type motif 12. [source:refseq;acc:nm\_031438]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2374\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent dna-directed rna polymerase iii largest subunit (ec 2.7.7.6) (rpc155) (rpc1). [source:swissprot;acc:o14802]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 3669.57\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 3520.86\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.04224\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2375\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent trna pseudouridine synthase a (ec 4.2.1.70) (pseudouridylate synthase i) (pseudouridine synthase i) (uracil hydrolyase). [source:swissprot;acc:q9y606]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 3650.02\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 3502.81\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.04203\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2376\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent cysteine-rich protein 1 (crp1) (crp). [source:swissprot;acc:p21291]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 3976.48\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 3816.38\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.04195\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2377\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent likely ortholog of mouse shc sh2-domain binding protein 1. [source:refseq;acc:nm\_024745]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 3977.7\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 3818.01\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.04183\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2378\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent smooth muscle cell lim protein (cysteine-rich protein 2) (crp2) (lim-only protein 5). [source:swissprot;acc:q16527]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 3977.76\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 3818.09\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.04182\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2379\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent lim domain protein, cardiac (muscle lim protein) (cysteine-rich protein 3) (crp3). [source:swissprot;acc:p50461]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 3979.06\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 3819.84\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.04168\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2380\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent suppressor of ty 5 homolog; suppressor of ty (s.cerevisiae) 5 homolog. [source:refseq;acc:nm\_003169]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 3690.79\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 3543.33\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.04162\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2381\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent dna-directed rna polymerase i largest subunit (ec 2.7.7.6) (rna polymerase i 194 kda subunit) (rpa194). [source:swissprot;acc:o95602]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 3667.94\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 3521.41\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.04161\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2382\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent hydroxyacid oxidase 2 (ec 1.1.3.15) (haox2) ((s)-2-hydroxy-acid oxidase, peroxisomal) (long chain alpha-hydroxy acid oxidase) (long- chain l-2-hydroxy acid oxidase). [source:swissprot;acc:q9nyq3]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 4457.6\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 4642.72\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.04153\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2383\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent calpain 2, large [catalytic] subunit precursor (ec 3.4.22.17) (calcium-activated neutral proteinase) (canp) (m-type) (m-calpain) (millimolar-calpain) (calpain large polypeptide l2). [source:swissprot;acc:p17655]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 4164.76\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 4337.01\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.04136\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2384\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent calpain 1, large [catalytic] subunit (ec 3.4.22.17) (calcium-activated neutral proteinase) (canp) (mu-type) (mucanp) (micromolar-calpain). [source:swissprot;acc:p07384]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 4164.96\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 4336.92\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.04129\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2385\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent adenylate kinase isoenzyme 2, mitochondrial (ec 2.7.4.3) (atp-amp transphosphorylase). [source:swissprot;acc:p54819]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 3716.43\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 3569.68\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.04111\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2386\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 60s ribosomal protein l30. [source:swissprot;acc:p04645]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 3674.02\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 3529.35\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.04099\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2387\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent cell division cycle protein 23; anaphase-promoting complex subunit 8. [source:refseq;acc:nm\_004661]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 8265.85\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 7940.87\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.04092\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2388\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent diphosphomevalonate decarboxylase (ec 4.1.1.33) (mevalonate pyrophosphate decarboxylase) (mevalonate (diphospho)decarboxylase). [source:swissprot;acc:p53602]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 4418.21\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 4594.87\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.03998\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2389\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent lipoate-protein ligase, mitochondrial precursor (ec 6.-.-.-) (lipoate biosynthesis protein) (lipoyl ligase) (lipoyltransferase). [source:swissprot;acc:q9y234]\vspace{3pt}}&\multirow{5}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 6327.14\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 6579.38\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.03987\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 2390\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent tubulin gamma-1 chain (gamma-1 tubulin) (gamma-tubulin complex component 1) (gcp-1). [source:swissprot;acc:p23258]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 2391\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent defender against cell death 1 (dad-1). [source:swissprot;acc:p46966]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 2392\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent t-complex 11. [source:refseq;acc:nm\_018679]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 2393\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent tubulin gamma-2 chain (gamma-2 tubulin). [source:swissprot;acc:q9nrh3]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2394\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent trifunctional purine biosynthetic protein adenosine-3 [includes: phosphoribosylamine--glycine ligase (ec 6.3.4.13) (gars) (glycinamide ribonucleotide synthetase) (phosphoribosylglycinamide synthetase); phosphoribosylformylglycinamidine cyclo-ligase (ec 6.3.3.1) (airs) (phosphoribosyl-aminoimidazole synthetase) (air synthase); phosphoribosylglycinamide formyltransferase (ec 2.1.2.2) (gart) (gar transformylase) (5'-phosphoribosylglycinamide transformylase)]. [source:swissprot;acc:p22102]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5502.5\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 5721.43\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.03979\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2395\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent homeobox protein otx2. [source:swissprot;acc:p32243]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5682\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 5905.08\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.03926\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2396\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent myofibrillogenesis regulator 1; trans-activated by hepatitis c virus core protein 2; likely ortholog of mouse brain protein 17. [source:refseq;acc:nm\_022572]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 6711.27\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6974.49\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.03922\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2397\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent yl-1 protein (transcription factor-like 1). [source:swissprot;acc:q15906]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 6707.29\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 6970.07\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.03918\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 2398\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent hydroxyacylglutathione hydrolase (ec 3.1.2.6) (glyoxalase ii) (glx ii). [source:swissprot;acc:q16775]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2399\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent homeobox protein otx1. [source:swissprot;acc:p32242]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5691.1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 5913.92\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.03915\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2400\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent malate dehydrogenase, mitochondrial precursor (ec 1.1.1.37). [source:swissprot;acc:p40926]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 4368.44\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 4539.34\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.03912\vspace{3pt}}}\\\cline{1-4} \parbox{\wcA}{\vspace{3pt}\noindent 2401\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent cone-rod homeobox protein. [source:swissprot;acc:o43186]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5694.04\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 5916.78\vspace{3pt}}&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2402\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 40s ribosomal protein sa (p40) (34/67 kda laminin receptor) (colon carcinoma laminin-binding protein) (nem/1chd4) (multidrug resistance- associated protein mgr1-ag). [source:swissprot;acc:p08865]\vspace{3pt}}&\multirow{10}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 5078.5\vspace{3pt}}}&\multirow{10}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 5275.76\vspace{3pt}}}&\multirow{10}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.03884\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 2403\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 40s ribosomal protein s21. [source:swissprot;acc:p35265]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 2404\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent cytoplasmic antiproteinase 3 (cap3) (cap-3) (protease inhibitor 9) (serpin b9). [source:swissprot;acc:p50453]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 2405\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent maspin precursor (protease inhibitor 5). [source:swissprot;acc:p36952]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 2406\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent bomapin (protease inhibitor 10) (serpin b10). [source:swissprot;acc:p48595]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 2407\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent plasminogen activator inhibitor-2 precursor (pai-2) (placental plasminogen activator inhibitor) (monocyte arg-serpin) (urokinase inhibitor). [source:swissprot;acc:p05120]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 2408\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent serpin b11. [source:swissprot;acc:q96p15]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 2409\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent placental thrombin inhibitor (cytoplasmic antiproteinase) (cap) (protease inhibitor 6) (pi-6). [source:swissprot;acc:p35237]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 2410\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent cytoplasmic antiproteinase 2 (cap2) (cap-2) (protease inhibitor 8) (serpin b8). [source:swissprot;acc:p50452]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 2411\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent leukocyte elastase inhibitor (lei) (monocyte/neutrophil elastase inhibitor) (m/nei) (ei). [source:swissprot;acc:p30740]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2412\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent dynactin 4. [source:refseq;acc:nm\_032486]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 4644.04\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 4470.47\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.03883\vspace{3pt}}\\\hline nd{longtable}
Legend:
- Rank is the rank after comparing the two networks
- Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray
- Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.
- Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them
- Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.
- Filtered specifies whether we only included the high confidence microarry measurements or not.

- http://analysis.yellowcouch.org/